Max Donley
2019 - Aurinia Pharmaceuticals
In 2019, Max Donley earned a total compensation of $945.9K as EVP, Operations and Strategy at Aurinia Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $177,600 |
|---|---|
| Option Awards | $598,154 |
| Salary | $168,299 |
| Other | $1,850 |
| Total | $945,903 |
Donley received $598.2K in option awards, accounting for 63% of the total pay in 2019.
Donley also received $177.6K in non-equity incentive plan, $168.3K in salary and $1.9K in other compensation.
Rankings
In 2019, Max Donley's compensation ranked 9,521st out of 13,971 executives tracked by ExecPay. In other words, Donley earned more than 31.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,521 out of 13,971 | 32nd |
Division Manufacturing | 3,831 out of 5,701 | 33rd |
Major group Chemicals And Allied Products | 1,455 out of 2,200 | 34th |
Industry group Drugs | 1,243 out of 1,886 | 34th |
Industry Pharmaceutical Preparations | 923 out of 1,398 | 34th |
Source: SEC filing on May 10, 2021.
Donley's colleagues
We found two more compensation records of executives who worked with Max Donley at Aurinia Pharmaceuticals in 2019.